Clinical trial
A Causative Role for Amylin in Diabetic Peripheral Neuropathy
NCT03481283 is registered in ClinicalTrials.gov with Zabeen Mahuwala, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Causative Role for Amylin in Diabetic Peripheral Neuropathy
- Lead sponsor
- Zabeen Mahuwala, MD
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 5, 2018
- Completion date
- January 31, 2029
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral neuropathy, type2 diabetes